FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
EPITALONGIGARESEARCH

EPITALON · SUBTOPIC · MECHANISM

EPITALON Mechanism

For Laboratory Research Use Only. The mechanistic information below is descriptive of published research. No human dose is recommended. No clinical claim is made.

MECHANISM OF ACTION

Four-amino-acid synthetic peptide (Ala-Glu-Asp-Gly) with telomerase-activating activity in human somatic cells. Developed at the St. Petersburg Institute of Bioregulation and Gerontology. Russian clinical use spans 30+ years; mainstream Western RCT-grade evidence is limited.

PHARMACOKINETIC HALF-LIFE

Reported half-life for EPITALON: Very short (minutes) plasma; tissue-localized longer. Half-life determines the kinetic window across which receptor occupancy is maintained and frames the dosing rhythm used in published literature.

PRIMARY SEQUENCE

EPITALON is a defined sequence: Ala-Glu-Asp-Gly. Synthesis proceeds via solid-phase peptide synthesis with HPLC-verified identity confirmation.

MECHANISM CATEGORIES

EPITALON is tagged in 1 mechanism category on GIGARESEARCH. Each category aggregates the broader pharmacology of related compounds.

The longevity category includes compounds acting on canonical aging-biology pathways: sirtuins (NAD+-dependent deacylases), mitochondrial function and biogenesis, cellular senescence, autophagy, and the AMPK/mTOR axis. NAD+ and its precursors are the most-studied longevity compounds; MOTS-c (mitochondrial-derived peptide) is an emerging category.

MECHANISTIC OUTCOMES IN LITERATURE

The following outcomes are the mechanistic endpoints reported in the peer-reviewed literature, with GIGARESEARCH evidence grades. Grades reflect study quality and replication, not clinical recommendation.

Telomerase activation (in vitro)GRADE C

Khavinson 2003 reported telomerase upregulation in human peripheral blood lymphocytes; replication outside Khavinson network is limited.

Long-term mortality (observational)GRADE D

12-year Russian observational study of 266 patients · not a randomized double-blind design; treat as preliminary.

MECHANISM Q+A

How does Epitalon work?

Proposed mechanisms include telomerase activation in somatic cells (Khavinson 2003, PMID 14523389), modulation of melatonin secretion via pineal gland action, and influence on circadian clock-gene expression. Replication outside the Khavinson network is limited.

CITED LITERATURE

  • Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett 2002. PMID 12624353. link
  • Khavinson V, et al.. Effects of pineal peptide preparation Epithalamin on free-radical processes in humans and animals. Neuro Endocrinol Lett 2003. PMID 14523389. link

RELATED PAGES

EPITALON OVERVIEWDOSING LITERATURE ▶SAFETY PROFILE ▶

▶ LAST UPDATED · 2026-05-19

© 2026 GigaCompounds LLC · For Laboratory Research Use Only